Zimberelimab Plus Lenvatinib After Progression on Prior Immune Checkpoint Inhibitors for Advanced Cervical Cancer

NCT05824468 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Cervical Cancer
Cervical Carcinoma

Interventions

DRUG: Zimberelimab
DRUG: Lenvatinib

Sponsor

Sun Yat-sen University